|
1
|
Zhu C, Zhang L, Ding X, Wu W and Zou J:
Non-coding RNAs as regulators of autophagy in chondrocytes:
Mechanisms and implications for osteoarthritis. Ageing Res Rev.
99:1024042024. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tang S, Zhang C, Oo WM, Fu K, Risberg MA,
Bierma-Zeinstra SM, Neogi T, Atukorala I, Malfait AM, Ding C and
Hunter DJ: Osteoarthritis. Nat Rev Dis Primers. 11:102025.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cao F, Xu Z, Li XX, Fu ZY, Han RY, Zhang
JL, Wang P, Hou S and Pan HF: Trends and cross-country inequalities
in the global burden of osteoarthritis, 1990-2019: A
population-based study. Ageing Res Rev. 99:1023822024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Courties A, Kouki I, Soliman N, Mathieu S
and Sellam J: Osteoarthritis year in review 2024: Epidemiology and
therapy. Osteoarthritis Cartilage. 32:1397–1404. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Turkiewicz A, Petersson IF, Björk J,
Hawker G, Dahlberg LE, Lohmander LS and Englund M: Current and
future impact of osteoarthritis on health care: A population-based
study with projections to year 2032. Osteoarthritis Cartilage.
22:1826–1832. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leifer VP, Katz JN and Losina E: The
burden of OA-health services and economics. Osteoarthritis
Cartilage. 30:10–16. 2022. View Article : Google Scholar
|
|
7
|
Katz JN, Arant KR and Loeser RF: Diagnosis
and treatment of Hip and knee osteoarthritis: A review. JAMA.
325:568–578. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kloppenburg M, Namane M and Cicuttini F:
Osteoarthritis. Lancet. 405:71–85. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wieland HA, Michaelis M, Kirschbaum BJ and
Rudolphi KA: Osteoarthritis-an untreatable disease? Nat Rev Drug
Discov. 4:331–344. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou R, Fu W, Vasylyev D, Waxman SG and
Liu CJ: Ion channels in osteoarthritis: Emerging roles and
potential targets. Nat Rev Rheumatol. 20:545–564. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pinals RS: Mechanisms of joint
destruction, pain and disability in osteoarthritis. Drugs. 52(Suppl
3): S14–S20. 1996. View Article : Google Scholar
|
|
12
|
Goldring SR and Goldring MB: Changes in
the osteochondral unit during osteoarthritis: Structure, function
and cartilage-bone crosstalk. Nat Rev Rheumatol. 12:632–644. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Knights AJ, Redding SJ and Maerz T:
Inflammation in osteoarthritis: The latest progress and ongoing
challenges. Curr Opin Rheumatol. 35:128–134. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mobasheri A, Rayman MP, Gualillo O, Sellam
J, van der Kraan P and Fearon U: The role of metabolism in the
pathogenesis of osteoarthritis. Nat Rev Rheumatol. 13:302–311.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Xin Y, Dong Z, Li S and Yang G:
The interplay between the immune microenvironment and bone aging:
From molecular mechanisms to therapeutic interventions. Exp
Gerontol. 212:1129742025. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang Y, Wang Z, Cao J and Tu Y: Bone-brain
crosstalk in osteoarthritis: Pathophysiology and interventions.
Trends Mol Med. 31:281–295. 2025. View Article : Google Scholar
|
|
17
|
Longo UG, Lalli A, Bandini B, de Sire R,
Angeletti S, Lustig S, Ammendolia A, Budhiparama NC and de Sire A:
Role of the gut microbiota in osteoarthritis, rheumatoid arthritis,
and spondylarthritis: An update on the gut-joint axis. Int J Mol
Sci. 25:32422024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han Z, Wang K, Ding S and Zhang M:
Cross-talk of inflammation and cellular senescence: A new insight
into the occurrence and progression of osteoarthritis. Bone Res.
12:692024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Veronese N, Cooper C, Reginster JY,
Hochberg M, Branco J, Bruyère O, Chapurlat R, Al-Daghri N, Dennison
E, Herrero-Beaumont G, et al: Type 2 diabetes mellitus and
osteoarthritis. Semin Arthritis Rheum. 49:9–19. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scotece M and Mobasheri A: Leptin in
osteoarthritis: Focus on articular cartilage and chondrocytes. Life
Sci. 140:75–78. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Collins KH, Lenz KL, Pollitt EN, Ferguson
D, Hutson I, Springer LE, Oestreich AK, Tang R, Choi YR, Meyer GA,
et al: Adipose tissue is a critical regulator of osteoarthritis.
Proc Natl Acad Sci USA. 118:e20210961182021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie C and Chen Q: Adipokines: New
therapeutic target for osteoarthritis? Curr Rheumatol Rep.
21:712019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ait Eldjoudi D, Cordero Barreal A,
Gonzalez-Rodríguez M, Ruiz-Fernández C, Farrag Y, Farrag M, Lago F,
Capuozzo M, Gonzalez-Gay MA, Mera Varela A, et al: Leptin in
osteoarthritis and rheumatoid arthritis: Player or bystander? Int J
Mol Sci. 23:28592022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gulati M, Dursun E, Vincent K and Watt FE:
The influence of sex hormones on musculoskeletal pain and
osteoarthritis. Lancet Rheumatol. 5:e225–e238. 2023. View Article : Google Scholar
|
|
25
|
Lan Y, Zheng Q, Li M, Chen J, Huang D and
Lin L: Associations between surrogate insulin resistance indexes
and osteoarthritis: NHANES 2003-2016. Sci Rep. 15:15782025.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sniekers YH, Weinans H, van Osch GJ and
van Leeuwen JP: Oestrogen is important for maintenance of cartilage
and subchondral bone in a murine model of knee osteoarthritis.
Arthritis Res Ther. 12:R1822010. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roman-Blas JA, Castañeda S, Largo R and
Herrero-Beaumont G: Osteoarthritis associated with estrogen
deficiency. Arthritis Res Ther. 11:2412009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ootake T, Ishii T, Sueishi K, Watanabe A,
Ishizuka Y, Amano K, Nagao M, Nishimura K and Nishii Y: Effects of
mechanical stress and deficiency of dihydrotestosterone or
17β-estradiol on temporomandibular joint osteoarthritis in mice.
Osteoarthritis Cartilage. 29:1575–1589. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gilmer G, Iijima H, Hettinger ZR, Jackson
N, Bergmann J, Bean AC, Shahshahan N, Creed E, Kopchak R, Wang K,
et al: Menopause-induced 17β-estradiol and progesterone loss
increases senescence markers, matrix disassembly and degeneration
in mouse cartilage. Nat Aging. 5:65–86. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu Z, Chen L, Zhao J, Zhang W, Jin Z, Sun
Y, Li Z, Chang B, Shen P and Yang Y: Lipoxin A4
ameliorates knee osteoarthritis progression in rats by antagonizing
ferroptosis through activation of the ESR2/LPAR3/Nrf2 axis in
synovial fibroblast-like synoviocytes. Redox Biol. 73:1031432024.
View Article : Google Scholar
|
|
31
|
Ushiyama T, Ueyama H, Inoue K, Ohkubo I
and Hukuda S: Expression of genes for estrogen receptors alpha and
beta in human articular chondrocytes. Osteoarthritis Cartilage.
7:560–566. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kinney RC, Schwartz Z, Week K, Lotz MK and
Boyan BD: Human articular chondrocytes exhibit sexual dimorphism in
their responses to 17beta-estradiol. Osteoarthritis Cartilage.
13:330–337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Srikanth VK, Fryer JL, Zhai G, Winzenberg
TM, Hosmer D and Jones G: A meta-analysis of sex differences
prevalence, incidence and severity of osteoarthritis.
Osteoarthritis Cartilage. 13:769–781. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ham KD, Loeser RF, Lindgren BR and Carlson
CS: Effects of long-term estrogen replacement therapy on
osteoarthritis severity in cynomolgus monkeys. Arthritis Rheum.
46:1956–1964. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yasuoka T, Nakashima M, Okuda T and
Tatematsu N: Effect of estrogen replacement on temporomandibular
joint remodeling in ovariectomized rats. J Oral Maxillofac Surg.
58:189–197. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gilmer G, Bean AC, Iijima H, Jackson N,
Thurston RC and Ambrosio F: Uncovering the 'riddle of femininity'
in osteoarthritis: A systematic review and meta-analysis of
menopausal animal models and mathematical modeling of estrogen
treatment. Osteoarthritis Cartilage. 31:447–457. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jin X, Wang BH, Wang X, Antony B, Zhu Z,
Han W, Cicuttini F, Wluka AE, Winzenberg T, Blizzard L, et al:
Associations between endogenous sex hormones and MRI structural
changes in patients with symptomatic knee osteoarthritis.
Osteoarthritis Cartilage. 25:1100–1106. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu H, Xiao W, Ding C, Zou J, Zhou D, Wang
J, Ding L, Jin C, Sun L and Li Y: Global burden of osteoarthritis
among postmenopausal women in 204 countries and territories: A
systematic analysis for the global burden of disease study 2021.
BMJ Glob Health. 10:e0171982025. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Almeida M, Laurent MR, Dubois V, Claessens
F, O'Brien CA, Bouillon R, Vanderschueren D and Manolagas SC:
Estrogens and androgens in skeletal physiology and pathophysiology.
Physiol Rev. 97:135–187. 2017. View Article : Google Scholar
|
|
40
|
Khosla S and Monroe DG: Regulation of bone
metabolism by sex steroids. Cold Spring Harb Perspect Med.
8:a0312112018. View Article : Google Scholar :
|
|
41
|
Jiang Z, Yao X, Yang Y, Tang F, Ma W, Yao
X and Lan W: The causal impact of bioavailable testosterone levels
on osteoarthritis: A bidirectional Mendelian randomized study. BMC
Musculoskelet Disord. 26:3872025. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ma N and Gao F: Correlation between low
testosterone levels and the risk of osteoarthritis: A
cross-sectional analysis of NHANES data (2011-2016). BMC
Musculoskelet Disord. 26:232025. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Szilagyi IA, Schiphof D, Chaker L, Boer
CG, Aribas E, Kavousi M, Ikram MA, Bierma-Zeinstra SMA and van
Meurs JBJ: Associations between testosterone and knee and hand
osteoarthritis among males and females from the general population.
Osteoarthritis Cartilage. 33:1237–1245. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang J, Yin J, Zhang X, Wang J, Xing X, Tu
J and Cai G: The association between endogenous sex hormones and
knee osteoarthritis in women: A population-based cohort study.
Osteoarthritis Cartilage. 33:1229–1236. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Masoud O, Morris L, Al-Hamdani M,
Al-Haidose A and Abdallah AM: Association between clinical
laboratory indicators and WOMAC scores in Qatar Biobank
participants: The impact of testosterone and fibrinogen on pain,
stiffness, and functional limitation. Scand J Pain. 25:2025.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Freystaetter G, Fischer K, Orav EJ, Egli
A, Theiler R, Münzer T, Felson DT and Bischoff-Ferrari HA: Total
serum testosterone and western ontario and mcmaster universities
osteoarthritis index pain and function among older men and women
with severe knee osteoarthritis. Arthritis Care Res (Hoboken).
72:1511–1518. 2020. View Article : Google Scholar :
|
|
47
|
Tian X and Zhang B: The association
between sex hormones and prevalence of OA in US adults. Front Med
(Lausanne). 11:14252102024. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pan Q, O'Connor MI, Coutts RD, Hyzy SL,
Olivares-Navarrete R, Schwartz Z and Boyan BD: Characterization of
osteoarthritic human knees indicates potential sex differences.
Biol Sex Differ. 7:272016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Parmar RP, Cronen A, Hui C, Stickels M,
Lederman E and Shah A: Testosterone replacement therapy is not
associated with greater revision rates in reverse total shoulder
arthroplasty. J Clin Med. 14:13412025. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cohn RM, Ganz MP and Scuderi GR:
Testosterone replacement therapy in orthopaedic surgery. J Am Acad
Orthop Surg. 32:331–338. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bassett JH and Williams GR: Role of
thyroid hormones in skeletal development and bone maintenance.
Endocr Rev. 37:135–187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li C, Tu Y, Rong R, Zhang Z, Chen W, Long
L, Zhang Y, Wang C, Pan B, Wu X, et al: Association of thyroid
hormone with osteoarthritis: From mendelian randomization and RNA
sequencing analysis. J Orthop Surg Res. 19:4292024. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
He Z, Gong Z, Jiao S, Xiong W, Hao X, Cui
J and Zhang J: Genetic predisposition to thyrotoxicosis and onset
of knee osteoarthritis. Front Endocrinol (Lausanne).
15:13640272024. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xu Y, Szilagyi IA, Boer CG,
Sedaghati-Khayat B, Visser WE, van Meurs JB and Chaker L:
Association between thyroid function and osteoarthritis: A
population-based cohort study. Osteoarthritis Cartilage.
33:888–896. 2025. View Article : Google Scholar
|
|
55
|
Chen S, Sun X, Zhou G, Jin J and Li Z:
Association between sensitivity to thyroid hormone indices and the
risk of osteoarthritis: An NHANES study. Eur J Med Res. 27:1142022.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Pörings AS, Lowin T, Dufner B, Grifka J
and Straub RH: A thyroid hormone network exists in synovial
fibroblasts of rheumatoid arthritis and osteoarthritis patients.
Sci Rep. 9:132352019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Luongo C, Dentice M and Salvatore D:
Deiodinases and their intricate role in thyroid hormone
homeostasis. Nat Rev Endocrinol. 15:479–488. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Deng Y, Han Y, Gao S, Dong W and Yu Y: The
physiological functions and polymorphisms of type II deiodinase.
Endocrinol Metab (Seoul). 38:190–202. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Bomer N, den Hollander W, Ramos YF, Bos
SD, van der Breggen R, Lakenberg N, Pepers BA, van Eeden AE,
Darvishan A, Tobi EW, et al: Underlying molecular mechanisms of
DIO2 susceptibility in symptomatic osteoarthritis. Ann Rheum Dis.
74:1571–1579. 2015. View Article : Google Scholar :
|
|
60
|
Dayan CM and Panicker V: Novel insights
into thyroid hormones from the study of common genetic variation.
Nat Rev Endocrinol. 5:211–218. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mohajer B, Moradi K, Guermazi A, Mammen
JSR, Hunter DJ, Roemer FW and Demehri S: Levothyroxine use and
longitudinal changes in thigh muscles in at-risk participants for
knee osteoarthritis: Preliminary analysis from osteoarthritis
initiative cohort. Arthritis Res Ther. 25:582023. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Jahanban-Esfahlan R, Mehrzadi S, Reiter
RJ, Seidi K, Majidinia M, Baghi HB, Khatami N, Yousefi B and
Sadeghpour A: Melatonin in regulation of inflammatory pathways in
rheumatoid arthritis and osteoarthritis: Involvement of circadian
clock genes. Br J Pharmacol. 175:3230–3238. 2018. View Article : Google Scholar
|
|
63
|
Hossain FM and Hong Y, Jin Y, Choi J and
Hong Y: Physiological and pathological role of circadian hormones
in osteoarthritis: Dose-dependent or time-dependent? J Clin Med.
8:14152019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Hosseinzadeh A, Kamrava SK, Joghataei MT,
Darabi R, Shakeri-Zadeh A, Shahriari M, Reiter RJ, Ghaznavi H and
Mehrzadi S: Apoptosis signaling pathways in osteoarthritis and
possible protective role of melatonin. J Pineal Res. 61:411–425.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang Q, Qi B, Shi S, Jiang W, Li D, Jiang
X and Yi C: Melatonin alleviates osteoarthritis by regulating NADPH
oxidase 4-induced ferroptosis and mitigating mitochondrial
dysfunction. J Pineal Res. 76:e129922024. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liu SC, Tsai CH, Wang YH, Su CM, Wu HC,
Fong YC, Yang SF and Tang CH: Melatonin abolished proinflammatory
factor expression and antagonized osteoarthritis progression in
vivo. Cell Death Dis. 13:2152022. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhao Z, Bi B, Cheng G, Zhao Y, Wu H, Zheng
M and Cao Z: Melatonin ameliorates osteoarthritis rat cartilage
injury by inhibiting matrix metalloproteinases and JAK2/STAT3
signaling pathway. Inflammopharmacology. 31:359–368. 2023.
View Article : Google Scholar
|
|
68
|
Ke C, Li H, Yang D, Ying H, Zhu H, Wang J,
Xu J and Wang L: Melatonin attenuates the progression of
osteoarthritis in rats by inhibiting inflammation and related
oxidative stress on the surface of knee cartilage. Orthop Surg.
14:2230–2237. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhou X, Zhang Y, Hou M, Liu H, Yang H,
Chen X, Liu T, He F and Zhu X: Melatonin prevents cartilage
degradation in early-stage osteoarthritis through activation of
miR-146a/NRF2/HO-1 axis. J Bone Miner Res. 37:1056–1072. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Guan H, Cao R, Zhang J, Liu C, Duan X,
Zhao Y, Xing F, Kong N, Li Y, Wu Z, et al: Melatonin attenuates
synovial hyperplasia, inflammation, and fibrosis and postpones
osteoarthritis progression. FASEB J. 40:e712952026. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Li S, Si H, Xu J, Liu Y and Shen B: The
therapeutic effect and mechanism of melatonin on osteoarthritis:
From the perspective of non-coding RNAs. Front Genet.
13:9689192022. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Li H, Zhou B, Wu J, Zhang Y, Zhang W,
Doherty M, Deng X, Wang N, Xie D, Wang Y, et al: Melatonin is a
potential novel analgesic agent for osteoarthritis: Evidence from
cohort studies in humans and preclinical research in rats. J Pineal
Res. 76:e129452024. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Liang H, Yan Y, Sun W, Ma X, Su Z, Liu Z,
Chen Y and Yu B: Preparation of melatonin-loaded nanoparticles with
targeting and sustained release function and their application in
osteoarthritis. Int J Mol Sci. 24:87402023. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Xiong Z, Peng G, Deng J, Liu M, Ning X,
Zhuang Y, Yang H and Sun H: Therapeutic targets and potential
delivery systems of melatonin in osteoarthritis. Front Immunol.
15:13319342024. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Paulino Silva KM, de Sousa FL, Alves ACB,
Rocha PA, da Costa HNAF, Ferreira WR, Reis TS, de Oliveira TKB,
Cabral Batista SR, Lapa Neto CJC, et al: Chondroprotective effect
of melatonin and strontium ranelate in animal model of
osteoarthritis. Heliyon. 7:e067602021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhang Y, Liu T, Yang H, He F and Zhu X:
Melatonin: A novel candidate for the treatment of osteoarthritis.
Ageing Res Rev. 78:1016352022. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Lu KH, Lu PW, Lu EW, Tang CH, Su SC, Lin
CW and Yang SF: The potential remedy of melatonin on
osteoarthritis. J Pineal Res. 71:e127622021. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Bagherifard A, Hosseinzadeh A, Koosha F,
Sheibani M, Karimi-Behnagh A, Reiter RJ and Mehrzadi S: Melatonin
and bone-related diseases: An updated mechanistic overview of
current evidence and future prospects. Osteoporos Int.
34:1677–1701. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Villafañe JH, Pedersini P, Bertozzi L,
Drago L, Fernandez-Carnero J, Bishop MD and Berjano P: Exploring
the relationship between chronic pain and cortisol levels in
subjects with osteoarthritis: Results from a systematic review of
the literature. Osteoarthritis Cartilage. 28:572–580. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Carlesso LC, Sturgeon JA and Zautra AJ:
Exploring the relationship between disease-related pain and
cortisol levels in women with osteoarthritis. Osteoarthritis
Cartilage. 24:2048–2054. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Mehta O, Vijay A, Gohir SA, Kelly T, Zhang
W, Doherty M, Walsh DA, Aithal G and Valdes AM: Serum metabolome
analysis identified amino-acid metabolism associated with pain in
people with symptomatic knee osteoarthritis-a cross-sectional
study. J Pain. 24:1251–1261. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Paschali M, Lazaridou A, Paschalis T,
Moradian JR, Sadora J, Vilsmark ES and Edwards RR: Individual
variation in diurnal cortisol in patients with knee osteoarthritis:
Clinical correlates. Int J Psychophysiol. 167:1–6. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Galuh S, Faught E, Klaassen I, Koorneef
LL, Brinks J, van Dijk EHC, Elewaut D, Schlingemann RO, Schaaf MJM,
Boon CJF and Meijer OC: The glucocorticoid receptor is affected by
its target ZBTB16 in a dissociated manner. J Endocrinol.
266:e2402832025. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Huang G, Zhong Y, Li W, Liao W and Wu P:
Causal relationship between parathyroid hormone and the risk of
osteoarthritis: A mendelian randomization study. Front Genet.
12:6869392021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Qu Z, Yang F, Yan Y, Huang J, Zhao J, Hong
J, Li S, Jiang G, Wang W and Yan S: A Mendelian randomization study
on the role of serum parathyroid hormone and 25-hydroxyvitamin D in
osteoarthritis. Osteoarthritis Cartilage. 29:1282–1290. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhang H, Bei M, Zheng Z, Liu N, Cao X,
Xiao Y, Lian Q, Wang Y, Hou X and Tian F: Parathyroid hormone
(1-34) attenuates cartilage degradation and preserves subchondral
bone micro-architecture in rats with patella
baja-induced-patellofemoral joint osteoarthritis. Calcif Tissue
Int. 111:87–95. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Shao LT, Gou Y, Fang JK, Hu YP, Lian QQ,
Yang Z, Zhang YY, Wang YD, Tian FM and Zhang L: The protective
effects of parathyroid hormone (1-34) on cartilage and subchondral
bone through down-regulating JAK2/STAT3 and WNT5A/ROR2 in a
collagenase-induced osteoarthritis mouse model. Orthop Surg.
13:1662–1672. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Shao L, Ding L, Li W, Zhang C, Xia Y, Zeng
M, Ye Z and Deng DYB: Let-7a-5p derived from parathyroid hormone
(1-34)-preconditioned BMSCs exosomes delays the progression of
osteoarthritis by promoting chondrocyte proliferation and
migration. Stem Cell Res Ther. 16:2992025. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Zhang M, Hu W, Cai C, Wu Y, Li J and Dong
S: Advanced application of stimuli-responsive drug delivery system
for inflammatory arthritis treatment. Mater Today Bio.
14:1002232022. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Swailem K, Sadhan M, Al-Mashramah GA and
Saghir MA: Association between vitamin D deficiency, inflammatory
markers, and knee osteoarthritis: A retrospective study. J Orthop
Surg Res. 20:7942025. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Saengsiwaritt W, Ngamtipakon P and
Udomsinprasert W: Vitamin D and autophagy in knee osteoarthritis: A
review. Int Immunopharmacol. 123:1107122023. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Chevalley T, Brandi ML, Cashman KD,
Cavalier E, Harvey NC, Maggi S, Cooper C, Al-Daghri N, Bock O,
Bruyère O, et al: Role of vitamin D supplementation in the
management of musculoskeletal diseases: Update from an European
society of clinical and economical aspects of osteoporosis,
osteoarthritis and musculoskeletal diseases (ESCEO) working group.
Aging Clin Exp Res. 34:2603–2623. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Kuswanto W and Baker MC: Repurposing drugs
for the treatment of osteoarthritis. Osteoarthritis Cartilage.
32:886–895. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Szulc M, Świątkowska-Stodulska R,
Pawłowska E and Derwich M: Vitamin D3 metabolism and its
role in temporomandibular joint osteoarthritis and autoimmune
thyroid diseases. Int J Mol Sci. 24:40802023. View Article : Google Scholar
|
|
95
|
Yuen KCJ: Growth hormone and bone:
Preclinical and clinical perspectives. Endocr Pract. 31:1197–1206.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Li Z and Li Y: Effect of growth hormone
releasing hormone on chondrocytes of osteoarthritis. Korean J
Intern Med. 37:222–229. 2022. View Article : Google Scholar :
|
|
97
|
Yoo KH, Thapa N, Chwae YJ, Yoon SH, Kim
BJ, Lee JO, Jang YN and Kim J: Transforming growth factor-β family
and stem cell-derived exosome therapeutic treatment in
osteoarthritis (review). Int J Mol Med. 49:622022. View Article : Google Scholar
|
|
98
|
Blaney Davidson EN, van der Kraan PM and
van den Berg WB: TGF-beta and osteoarthritis. Osteoarthritis
Cartilage. 15:597–604. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Ma K, Singh G, Wang J, O-Sullivan I,
Votta-Velis G, Bruce B, Anbazhagan AN, van Wijnen AJ and Im HJ:
Targeting vascular endothelial growth factor receptors as a
therapeutic strategy for osteoarthritis and associated pain. Int J
Biol Sci. 19:675–690. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Sampath SJP, Venkatesan V, Ghosh S and
Kotikalapudi N: Obesity, metabolic syndrome, and osteoarthritis-an
updated review. Curr Obes Rep. 12:308–331. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
huo Q, Yang W, Chen J and Wang Y:
Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol.
8:729–737. 2012. View Article : Google Scholar
|
|
102
|
Jansen NEJ, Molendijk E, Schiphof D, van
Meurs JBJ, Oei EHG, van Middelkoop M and Bierma-Zeinstra SMA:
Metabolic syndrome and the progression of knee osteoarthritis on
MRI. Osteoarthritis Cartilage. 31:647–655. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Jiménez-Muro M, Soriano-Romaní L, Mora G,
Ricciardelli D and Nieto JA: The microbiota-metabolic syndrome axis
as a promoter of metabolic osteoarthritis. Life Sci.
329:1219442023. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Warmink K, Vinod P, Korthagen NM, Weinans
H and Rios JL: Macrophage-driven inflammation in metabolic
osteoarthritis: Implications for biomarker and therapy development.
Int J Mol Sci. 24:61122023. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Zhang C, Mao Y, Xin Y, Li H, Cai M, Lin Y,
Zhang X, Huang Y, Chen Y, Huang Z, et al: Fatty acid binding
protein 4 induces osteogenesis and angiogenesis as pathogenesis of
metabolic osteoarthritis. Mol Med. 32:92025. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Kim D, Ansari MM, Ghosh M, Heo Y, Choi KC
and Son YO: Implications of obesity-mediated cellular dysfunction
and adipocytokine signaling pathways in the pathogenesis of
osteoarthritis. Mol Aspects Med. 103:1013612025. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
De Roover A, Escribano-Núñez A, Monteagudo
S and Lories R: Fundamentals of osteoarthritis: Inflammatory
mediators in osteoarthritis. Osteoarthritis Cartilage.
31:1303–1311. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Binvignat M, Sellam J, Berenbaum F and
Felson DT: The role of obesity and adipose tissue dysfunction in
osteoarthritis pain. Nat Rev Rheumatol. 20:565–584. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Kroon FPB, Veenbrink AI, de Mutsert R,
Visser AW, van Dijk KW, le Cessie S, Rosendaal FR and Kloppenburg
M: The role of leptin and adiponectin as mediators in the
relationship between adiposity and hand and knee osteoarthritis.
Osteoarthritis Cartilage. 27:1761–1767. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Ilia I, Nitusca D and Marian C:
Adiponectin in osteoarthritis: Pathophysiology, relationship with
obesity and presumptive diagnostic biomarker potential. Diagnostics
(Basel). 12:4552022. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Feng X, Xiao J and Bai L: Role of
adiponectin in osteoarthritis. Front Cell Dev Biol. 10:9927642022.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Franco-Trepat E, Guillán-Fresco M,
Alonso-Pérez A, Jorge-Mora A, Francisco V, Gualillo O and Gómez R:
Visfatin connection: Present and future in osteoarthritis and
osteoporosis. J Clin Med. 8:11782019. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Zhou H, Xiao Y, Xue X, Liu J, Xu H, Wang
J, Zhou J, Zuo Q, Liang W, Song H, et al: Hyperglycemia exacerbates
osteoarthritis by impairing macrophage efferocytosis through
modulation of CD11b lactylation. Nat Commun. 17:7242025. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Li Q, Wen Y, Wang L, Chen B, Chen J, Wang
H and Chen L: Hyperglycemia-induced accumulation of advanced
glycosylation end products in fibroblast-like synoviocytes promotes
knee osteoarthritis. Exp Mol Med. 53:1735–1747. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Selvi NMK, Nandhini S, Sakthivadivel V,
Lokesh S, Srinivasan AR and Sumathi S: Association of
triglyceride-glucose index (TyG index) with HbA1c and insulin
resistance in type 2 diabetes mellitus. Maedica (Bucur).
16:375–381. 2021.PubMed/NCBI
|
|
116
|
Huang J, Rozi R, Ma J, Fu B, Lu Z, Liu J
and Ding Y: Association between higher triglyceride glucose index
and increased risk of osteoarthritis: Data from NHANES 2015-2020.
BMC Public Health. 24:7582024. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Zhang S, Jiang Z, Liao H, Bian H, Zhou J,
Wang H and Jiang T: Association between obesity indices, insulin
resistance markers, and osteoarthritis in middle-aged and elderly
Chinese adults. Front Nutr. 12:16274212025. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Weng Y, Yang H, Li L, Lv S and Chen G:
Association between the metabolic score for insulin resistance and
osteoarthritis prevalence: A cross-sectional population-based
study. Medicine (Baltimore). 104:e448502025. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Qiao L, Li Y and Sun S: Insulin
exacerbates inflammation in fibroblast-like synoviocytes.
Inflammation. 43:916–936. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Tchetina EV, Markova GA and Sharapova EP:
Insulin resistance in osteoarthritis: Similar mechanisms to type 2
diabetes mellitus. J Nutr Metab. 2020:41438022020. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Zheng J, Huang X, Huang J, Meng B, Li F,
Liu H, Chen L, Zhou R, Zou M and Wu X: Association of diabetes
mellitus status and hyperglycemia with symptomatic knee
osteoarthritis. Arthritis Care Res (Hoboken). 75:509–518. 2023.
View Article : Google Scholar
|
|
122
|
Halabitska I, Babinets L, Oksenych V and
Kamyshnyi O: Diabetes and osteoarthritis: Exploring the
interactions and therapeutic implications of insulin, metformin,
and GLP-1-based interventions. Biomedicines. 12:16302024.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Xiong J, Long J, Chen X, Li Y and Song H:
Dyslipidemia might be associated with an increased risk of
osteoarthritis. Biomed Res Int. 2020:31052482020. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Hsueh TY and Chen YP: The association
between dyslipidemia and hand osteoarthritis: A systematic review
and meta-analysis. Clin Rheumatol. 44:1439–1448. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Xie Y, Zhou W, Zhong Z, Zhao Z, Yu H,
Huang Y and Zhang P: Metabolic syndrome, hypertension, and
hyperglycemia were positively associated with knee osteoarthritis,
while dyslipidemia showed no association with knee osteoarthritis.
Clin Rheumatol. 40:711–724. 2021. View Article : Google Scholar
|
|
126
|
Chen X, Liu J and Wang G: Dyslipidemia in
osteoarthritis: A study combining bibliometric analysis and
retrospective data mining. Medicine (Baltimore). 104:e422302025.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Yan L, Ge H, Xu Q, Jiang D, Shen A, Yang
M, Zheng Y and Cao Y: Dyslipidemia induced inflammation mediated
the association between obesity and Osteoarthritis: A
population-based study. BMC Public Health. 24:31552024. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Cao C, Shi Y, Zhang X, Li Q, Zhang J, Zhao
F, Meng Q, Dai W, Liu Z, Yan W, et al: Cholesterol-induced LRP3
downregulation promotes cartilage degeneration in osteoarthritis by
targeting Syndecan-4. Nat Commun. 13:71392022. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Lee G, Yang J, Kim SJ, Tran TT, Lee SY,
Park KH, Kwon SH, Chung KH, Koh JT, Huh YH, et al: Enhancement of
intracellular cholesterol efflux in chondrocytes leading to
alleviation of osteoarthritis progression. Arthritis Rheumatol.
77:151–162. 2025. View Article : Google Scholar :
|
|
130
|
Mei Z, Yilamu K, Ni W, Shen P, Pan N, Chen
H, Su Y, Guo L, Sun Q, Li Z, et al: Chondrocyte fatty acid
oxidation drives osteoarthritis via SOX9 degradation and epigenetic
regulation. Nat Commun. 16:48922025. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Abshirini M, Ilesanmi-Oyelere BL and
Kruger MC: Potential modulatory mechanisms of action by long-chain
polyunsaturated fatty acids on bone cell and chondrocyte
metabolism. Prog Lipid Res. 83:1011132021. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Zou Z, Hu W, Kang F, Xu Z, Li Y, Zhang J,
Li J, Zhang Y and Dong S: Interplay between lipid dysregulation and
ferroptosis in chondrocytes and the targeted therapy effect of
metformin on osteoarthritis. J Adv Res. 69:515–529. 2025.
View Article : Google Scholar :
|
|
133
|
Hashimoto K and Akagi M: The role of
oxidation of low-density lipids in pathogenesis of osteoarthritis:
A narrative review. J Int Med Res. 48:3000605209316092020.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Hashimoto K, Mori S, Oda Y, Nakano A,
Sawamura T and Akagi M: Lectin-like oxidized low density
lipoprotein receptor 1-deficient mice show resistance to
instability-induced osteoarthritis. Scand J Rheumatol. 45:412–422.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Lee JS, Kim YH, Jhun J, Na HS, Um IG, Choi
JW, Woo JS, Kim SH, Shetty AA, Kim SJ and Cho ML: Oxidized LDL
accelerates cartilage destruction and inflammatory chondrocyte
death in osteoarthritis by disrupting the TFEB-regulated
autophagy-lysosome pathway. Immune Netw. 24:e152024. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Shen P, Zhu Y, Zhu L, Weng F, Li X and Xu
Y: Oxidized low density lipoprotein facilitates tumor necrosis
factor-α mediated chondrocyte death via autophagy pathway. Mol Med
Rep. 16:9449–9456. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
de Munter W, van der Kraan PM, van den
Berg WB and van Lent PL: High systemic levels of low-density
lipoprotein cholesterol: Fuel to the flames in inflammatory
osteoarthritis? Rheumatology (Oxford). 55:16–24. 2016. View Article : Google Scholar
|
|
138
|
You Y, Xiang T, Yang C, Xiao S, Tang Y,
Luo G, Ling Z, Luo F and Chen Y: Interactions between the gut
microbiota and immune cell dynamics: Novel insights into the
gut-bone axis. Gut Microbes. 17:25454172025. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Fu L, Zhang P, Wang Y and Liu X:
Microbiota-bone axis in ageing-related bone diseases. Front
Endocrinol (Lausanne). 15:14143502024. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Wei J, Zhang C, Zhang Y, Zhang W, Doherty
M, Yang T, Zhai G, Obotiba AD, Lyu H, Zeng C and Lei G: Association
between gut microbiota and symptomatic hand osteoarthritis: Data
from the Xiangya osteoarthritis study. Arthritis Rheumatol.
73:1656–1662. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Guido G, Ausenda G, Iascone V and Chisari
E: Gut permeability and osteoarthritis, towards a mechanistic
understanding of the pathogenesis: A systematic review. Ann Med.
53:2380–2390. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Koh A, De Vadder F, Kovatcheva-Datchary P
and Bäckhed F: From dietary fiber to host physiology: short-chain
fatty acids as key bacterial metabolites. Cell. 165:1332–1345.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Hu J, Lin S, Zheng B and Cheung PCK:
Short-chain fatty acids in control of energy metabolism. Crit Rev
Food Sci Nutr. 58:1243–1249. 2018. View Article : Google Scholar
|
|
144
|
Han J, Meng X, Kong H, Li X, Chen P and
Zhang XA: Links between short-chain fatty acids and osteoarthritis
from pathology to clinic via gut-joint axis. Stem Cell Res Ther.
16:2512025. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Mann ER, Lam YK and Uhlig HH: Short-chain
fatty acids: Linking diet, the microbiome and immunity. Nat Rev
Immunol. 24:577–595. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Postler TS and Ghosh S: Understanding the
holobiont: how microbial metabolites affect human health and shape
the immune system. Cell Metab. 26:110–130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Pirozzi C, Francisco V, Guida FD, Gómez R,
Lago F, Pino J, Meli R and Gualillo O: Butyrate modulates
inflammation in chondrocytes via GPR43 receptor. Cell Physiol
Biochem. 51:228–243. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Cho KH, Na HS, Jhun J, Woo JS, Lee AR, Lee
SY, Lee JS, Um IG, Kim SJ, Park SH and Cho ML: Lactobacillus (LA-1)
and butyrate inhibit osteoarthritis by controlling autophagy and
inflammatory cell death of chondrocytes. Front Immunol.
13:9305112022. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Korsten SGPJ, Hartog M, Berends AJ,
Koenders MI, Popa CD, Vromans H, Garssen J, van de Ende CHM,
Vermeiden JPW and Willemsen LEM: A sustained-release butyrate
tablet suppresses ex vivo T helper cell activation of
osteoarthritis patients in a double-blind placebo-controlled
randomized trial. Nutrients. 16:33842024. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Karim A, Khan HA, Ahmad F and Qaisar R:
Butyrate (short-chain fatty acid) alleviates
lipopolysaccharide-binding proteins and improves physical function
in knee osteoarthritis patients. Int J Biol Macromol.
307:1420172025. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Hartley A, Sanderson E, Paternoster L,
Teumer A, Kaplan RC, Tobias JH and Gregson CL: Mendelian
randomization provides evidence for a causal effect of higher serum
IGF-1 concentration on risk of hip and knee osteoarthritis.
Rheumatology (Oxford). 60:1676–1686. 2021. View Article : Google Scholar :
|
|
152
|
Shu Z, Miao X, Tang T, Zhan P, Zeng L and
Jiang Y: The GSK-3β/ β-catenin signaling pathway is involved in
HMGB1-induced chondrocyte apoptosis and cartilage matrix
degradation. Int J Mol Med. 45:769–778. 2020.PubMed/NCBI
|
|
153
|
van Lent PLEM, Blom AB, Schelbergen RFP,
Slöetjes A, Lafeber FPJG, Lems WF, Cats H, Vogl T, Roth J and van
den Berg WB: Active involvement of alarmins S100A8 and S100A9 in
the regulation of synovial activation and joint destruction during
mouse and human osteoarthritis. Arthritis Rheum. 64:1466–1476.
2012. View Article : Google Scholar
|
|
154
|
Zhang B, Chen H, Ouyang J, Xie Y and Chen
L, Tan Q, Du X, Su N, Ni Z and Chen L: SQSTM1-dependent autophagic
degradation of PKM2 inhibits the production of mature IL1B/IL-1β
and contributes to LIPUS-mediated anti-inflammatory effect.
Autophagy. 16:1262–1278. 2020. View Article : Google Scholar :
|
|
155
|
Weng M, Yang Z and Feng X: Serum
miR-576-5p as a novel diagnostic biomarker and therapeutic target
for osteoarthritis via targeting KLF10-mediated chondrocyte
dysfunction. BMC Musculoskelet Disord. 26:10882025. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Terkawi MA, Ebata T, Yokota S, Takahashi
D, Endo T, Matsumae G, Shimizu T, Kadoya K and Iwasaki N: Low-grade
inflammation in the pathogenesis of osteoarthritis: Cellular and
molecular mechanisms and strategies for future therapeutic
intervention. Biomedicines. 10:11092022. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Shi J and Du G: Metabolic reprogramming of
glycolysis favors cartilage progenitor cells rejuvenation. Joint
Bone Spine. 91:1056342024. View Article : Google Scholar
|
|
158
|
Liu B, Xian Y, Chen X, Shi Y, Dong J, Yang
L, An X, Shen T, Wu W, Ma Y, et al: Inflammatory fibroblast-like
synoviocyte-derived exosomes aggravate osteoarthritis via enhancing
macrophage glycolysis. Adv Sci (Weinh). 11:e23073382024. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Arra M, Swarnkar G, Ke K, Otero JE, Ying
J, Duan X, Maruyama T, Rai MF, O'Keefe RJ, Mbalaviele G, et al:
LDHA-mediated ROS generation in chondrocytes is a potential
therapeutic target for osteoarthritis. Nat Commun. 11:34272020.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Lan W, Chen X, Yu H, Ruan J, Kang J, Nie
X, Cao Y, Tang S and Ding C: UGDH lactylation aggravates
osteoarthritis by suppressing glycosaminoglycan synthesis and
orchestrating nucleocytoplasmic transport to activate MAPK
signaling. Adv Sci (Weinh). 12:e24137092025. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Huang YF, Wang G, Ding L, Bai ZR, Leng Y,
Tian JW, Zhang JZ, Li YQ, Ahmad, Qin YH, et al: Lactate-upregulated
NADPH-dependent NOX4 expression via HCAR1/PI3K pathway contributes
to ROS-induced osteoarthritis chondrocyte damage. Redox Biol.
67:1028672023. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Liu X, Li Y, Zhao J, Hu Z, Fang W, Ke J,
Li W and Long X: Pyroptosis of chondrocytes activated by synovial
inflammation accelerates TMJ osteoarthritis cartilage degeneration
via ROS/NLRP3 signaling. Int Immunopharmacol. 124:1107812023.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Liu D, Cai ZJ, Yang YT, Lu WH, Pan LY,
Xiao WF and Li YS: Mitochondrial quality control in cartilage
damage and osteoarthritis: New insights and potential therapeutic
targets. Osteoarthritis Cartilage. 30:395–405. 2022. View Article : Google Scholar
|
|
164
|
Shen T, Alvarez-Garcia O, Li Y, Olmer M
and Lotz MK: Suppression of Sestrins in aging and osteoarthritic
cartilage: Dysfunction of an important stress defense mechanism.
Osteoarthritis Cartilage. 25:287–296. 2017. View Article : Google Scholar
|
|
165
|
Wang B and Zhang H, Fan Z, Shi H, Huang F
and Zhang H: KLF5 aggravates osteoarthritis progression by
inhibiting chondrocyte autophagy via transcriptional activation of
PLK2. Sci Rep. 15:389632025. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Bohensky J, Leshinsky S, Srinivas V and
Shapiro IM: Chondrocyte autophagy is stimulated by HIF-1 dependent
AMPK activation and mTOR suppression. Pediatr Nephrol. 25:633–642.
2010. View Article : Google Scholar
|
|
167
|
Zhuang H, Ren X, Zhang Y, Li H and Zhou P:
β-Hydroxybutyrate enhances chondrocyte mitophagy and reduces
cartilage degeneration in osteoarthritis via the
HCAR2/AMPK/PINK1/Parkin pathway. Aging Cell. 23:e142942024.
View Article : Google Scholar
|
|
168
|
Lin X, Liu H, Qiao L, Deng H, Bao M, Yang
Z, He Y, Xiang R, He H and Han J: Chondrocyte autophagy mediated by
T-2 toxin via AKT/TSC/Rheb/mTOR signaling pathway and protective
effect of CSA-SeNP. Osteoarthritis Cartilage. 32:1283–1294. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Liu L, Zhang W, Liu T, Tan Y, Chen C, Zhao
J, Geng H and Ma C: The physiological metabolite α-ketoglutarate
ameliorates osteoarthritis by regulating mitophagy and oxidative
stress. Redox Biol. 62:1026632023. View Article : Google Scholar
|
|
170
|
Lin S, Wu B, Hu X and Lu H: Sirtuin 4
(Sirt4) downregulation contributes to chondrocyte senescence and
osteoarthritis via mediating mitochondrial dysfunction. Int J Biol
Sci. 20:1256–1278. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Chen Y, Wu YY, Si HB, Lu YR and Shen B:
Mechanistic insights into AMPK-SIRT3 positive feedback
loop-mediated chondrocyte mitochondrial quality control in
osteoarthritis pathogenesis. Pharmacol Res. 166:1054972021.
View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Li H, Chen P, Cheng W, Zhang Z, Yang J,
Zhang H, Jin F, Kan L, Chen L and Wang H: Programmed cell death in
osteoarthritis. Apoptosis. 31:32026. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Chen B, Wang L, Xie D and Wang Y:
Exploration and breakthrough in the mode of chondrocyte death-A
potential new mechanism for osteoarthritis. Biomed Pharmacother.
170:1159902024. View Article : Google Scholar
|
|
174
|
Guan M, Yu Q, Zhou G, Wang Y, Yu J, Yang W
and Li Z: Mechanisms of chondrocyte cell death in osteoarthritis:
Implications for disease progression and treatment. J Orthop Surg
Res. 19:5502024. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Li X, Ji L, Men X, Chen X, Zhi M, He S and
Chen S: Pyroptosis in bone loss. Apoptosis. 28:293–312. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Lou C, Fang Y, Mei Y, Hu W, Sun L, Jin C,
Chen H and Zheng W: Cucurbitacin B attenuates osteoarthritis
development by inhibiting NLRP3 inflammasome activation and
pyroptosis through activating Nrf2/HO-1 pathway. Phytother Res.
38:3352–3369. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Ebata T, Terkawi MA, Kitahara K, Yokota S,
Shiota J, Nishida Y, Matsumae G, Alhasan H, Hamasaki M, Hontani K,
et al: Noncanonical pyroptosis triggered by macrophage-derived
extracellular vesicles in chondrocytes leading to cartilage
catabolism in osteoarthritis. Arthritis Rheumatol. 75:1358–1369.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Tang H, Gong X, Dai J, Gu J, Dong Z, Xu Y,
Hu Z, Zhao C, Deng J and Dong S: The IRF1/GBP5 axis promotes
osteoarthritis progression by activating chondrocyte pyroptosis. J
Orthop Translat. 44:47–59. 2023. View Article : Google Scholar
|
|
179
|
Ru Q, Li Y, Xie W, Ding Y, Chen L, Xu G,
Wu Y and Wang F: Fighting age-related orthopedic diseases: Focusing
on ferroptosis. Bone Res. 11:122023. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Miao Y, Chen Y, Xue F, Liu K, Zhu B, Gao
J, Yin J, Zhang C and Li G: Contribution of ferroptosis and GPX4's
dual functions to osteoarthritis progression. EBioMedicine.
76:1038472022. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Wang S, Li W, Zhang P, Wang Z, Ma X, Liu
C, Vasilev K, Zhang L, Zhou X, Liu L, et al: Mechanical overloading
induces GPX4-regulated chondrocyte ferroptosis in osteoarthritis
via Piezo1 channel facilitated calcium influx. J Adv Res. 41:63–75.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Sun K, Hou L, Guo Z, Wang G, Guo J, Xu J,
Zhang X and Guo F: JNK-JUN-NCOA4 axis contributes to chondrocyte
ferroptosis and aggravates osteoarthritis via ferritinophagy. Free
Radic Biol Med. 200:87–101. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Xia S, Li L, Shi Z, Sun N and He Y:
Ferroptosis in osteoarthritis: Metabolic reprogramming,
immunometabolic crosstalk, and targeted intervention strategies.
Front Immunol. 16:16046522025. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Chen BY, Pathak JL, Lin HY, Guo WQ, Chen
WJ, Luo G, Wang LJ, Sun XF, Ding Y, Li J, et al: Inflammation
triggers chondrocyte ferroptosis in TMJOA via HIF-1α/TFRC. J Dent
Res. 103:712–722. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Stolberg-Stolberg J, Sambale M, Hansen U,
Raschke ASM, Bertrand J, Pap T and Sherwood J: Cartilage trauma
induces necroptotic chondrocyte death and expulsion of cellular
contents. Int J Mol Sci. 21:42042020. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Khaleque MA, Kim JH, Tanvir MAH, Park JB
and Kim YY: Significance of necroptosis in cartilage degeneration.
Biomolecules. 14:11922024. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Tsvetkov P, Coy S, Petrova B, Dreishpoon
M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R,
Spangler RD, et al: Copper induces cell death by targeting
lipoylated TCA cycle proteins. Science. 375:1254–1261. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Chang B, Hu Z, Chen L, Jin Z and Yang Y:
Development and validation of cuproptosis-related genes in
synovitis during osteoarthritis progress. Front Immunol.
14:10905962023. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Jiang Z, Li J, Shi M, Li Y, Sun N, Xi K,
Li X, Zhao D, Leng X, Zhou Z and Dong H: Hypoxia, cuproptosis, and
osteoarthritis: Unraveling the molecular crosstalk. Redox Biol.
85:1037572025. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Zhou D, Luo Y, Li F, Liu T, Mei Y, Li F,
Hou X, Fu Z and Liu Z: Exploring the mechanisms of PANoptosis in
osteoarthritis and the therapeutic potential of andrographolide
through bioinformatics and single-cell analysis. Biol Direct.
20:412025. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Loeser RF, Collins JA and Diekman BO:
Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol.
12:412–420. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Coryell PR, Diekman BO and Loeser RF:
Mechanisms and therapeutic implications of cellular senescence in
osteoarthritis. Nat Rev Rheumatol. 17:47–57. 2021. View Article : Google Scholar
|
|
193
|
Chen X, Gong W, Shao X, Shi T, Zhang L,
Dong J, Shi Y, Shen S, Qin J, Jiang Q and Guo B: METTL3-mediated
m6A modification of ATG7 regulates autophagy-GATA4 axis
to promote cellular senescence and osteoarthritis progression. Ann
Rheum Dis. 81:87–99. 2022. View Article : Google Scholar
|
|
194
|
Roh K, Noh J, Kim Y, Jang Y, Kim J, Choi
H, Lee Y, Ji M, Kang D, Kim MS, et al: Lysosomal control of
senescence and inflammation through cholesterol partitioning. Nat
Metab. 5:398–413. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Faust HJ, Zhang H, Han J, Wolf MT, Jeon
OH, Sadtler K, Peña AN, Chung L, Maestas DR Jr, Tam AJ, et al:
IL-17 and immunologically induced senescence regulate response to
injury in osteoarthritis. J Clin Invest. 130:5493–5507. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Jeon OH, Kim C, Laberge RM, Demaria M,
Rathod S, Vasserot AP, Chung JW, Kim DH, Poon Y, David N, et al:
Local clearance of senescent cells attenuates the development of
post-traumatic osteoarthritis and creates a pro-regenerative
environment. Nat Med. 23:775–781. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Diekman BO, Sessions GA, Collins JA,
Knecht AK, Strum SL, Mitin NK, Carlson CS, Loeser RF and Sharpless
NE: Expression of p16INK4a is a biomarker of chondrocyte
aging but does not cause osteoarthritis. Aging Cell. 17:e127712018.
View Article : Google Scholar
|
|
198
|
Kakiuchi Y, Yurube T, Kakutani K, Takada
T, Ito M, Takeoka Y, Kanda Y, Miyazaki S, Kuroda R and Nishida K:
Pharmacological inhibition of mTORC1 but not mTORC2 protects
against human disc cellular apoptosis, senescence, and
extracellular matrix catabolism through Akt and autophagy
induction. Osteoarthritis Cartilage. 27:965–976. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Huang Y, Yue S, Yan Z, Liu Y, Qiao J,
Zhang M, Dong Y and Zheng J: Lactate-upregulated ARG2 expression
induces cellular senescence in fibroblast-like synoviocytes of
osteoarthritis via activating the mTOR/S6K1 signaling pathway. Int
Immunopharmacol. 142:1130712024. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Lu H, Jia C, Wu D, Jin H, Lin Z, Pan J, Li
X and Wang W: Fibroblast growth factor 21 (FGF21) alleviates
senescence, apoptosis, and extracellular matrix degradation in
osteoarthritis via the SIRT1-mTOR signaling pathway. Cell Death
Dis. 12:8652021. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Hou WY, Zhu CY, Gu YF, Zhu L and Zhou ZX:
Association of hormone replacement therapy and the risk of knee
osteoarthritis: A meta-analysis. Medicine (Baltimore).
101:e324662022. View Article : Google Scholar :
|
|
202
|
Burkard T, Rauch M, Spoendlin J,
Prieto-Alhambra D, Jick SS and Meier CR: Risk of hand
osteoarthritis in new users of hormone replacement therapy: A
nested case-control analysis. Maturitas. 132:17–23. 2020.
View Article : Google Scholar
|
|
203
|
Williams JAE, Chester-Jones M, Minns Lowe
C, Goff MV, Francis A, Brewer G, Marian I, Morris SL, Warwick D,
Eldridge L, et al: Hormone replacement therapy (conjugated
oestrogens plus bazedoxifene) for post-menopausal women with
symptomatic hand osteoarthritis: Primary report from the HOPE-e
randomised, placebo-controlled, feasibility study. Lancet
Rheumatol. 4:e725–e737. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Pang H, Chen S, Klyne DM, Harrich D, Ding
W, Yang S and Han FY: Low back pain and osteoarthritis pain: A
perspective of estrogen. Bone Res. 11:422023. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Sun M, Ma B, Pan Z, Zhao Y, Tian L, Fan Y,
Kong W, Wang J, Xu B, Ao Y, et al: Targeted therapy of
osteoarthritis via intra-articular delivery of
lipid-nanoparticle-encapsulated recombinant human FGF18 mRNA. Adv
Healthc Mater. 13:e24008042024. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Li G, Liu S, Chen Y, Zhao J, Xu H, Weng J,
Yu F, Xiong A, Udduttula A, Wang D, et al: An injectable
liposome-anchored teriparatide incorporated gallic acid-grafted
gelatin hydrogel for osteoarthritis treatment. Nat Commun.
14:31592023. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Gupta N, Khatri K, Lakhani A, Dahuja A,
Randhawa A, Bansal V and Bansal K: Long-term effectiveness of
intra-articular injectables in patients with knee osteoarthritis: A
systematic review and Bayesian network meta-analysis. J Orthop Surg
Res. 20:2272025. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Liu J, Huang X, Lv T, Cao L and Lu L:
Intra-articular injection of chitosan combined with low-dose
glucocorticoid for the treatment of knee osteoarthritis in early
and middle stages. Medicine (Baltimore). 103:e399242024. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Ok SM, Kim JH, Kim JS, Jeong EG, Park YM,
Jeon HM, Heo JY, Ahn YW, Yu SN, Park HR, et al: Local injection of
growth hormone for temporomandibular joint osteoarthritis. Yonsei
Med J. 61:331–340. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Meurot C, Martin C, Sudre L, Breton J,
Bougault C, Rattenbach R, Bismuth K, Jacques C and Berenbaum F:
Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts
analgesic, anti-inflammatory and anti-degradative actions in
osteoarthritis. Sci Rep. 12:15672022. View Article : Google Scholar
|
|
211
|
Karacabeyli D and Lacaille D:
Glucagon-like peptide-1 receptor agonists in arthritis: Current
insights and future directions. Nat Rev Rheumatol. 21:671–683.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Ryan M, Megyeri S, Nuffer W and Trujillo
JM: The potential role of GLP-1 receptor agonists in
osteoarthritis. Pharmacotherapy. 45:177–186. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Bliddal H, Bays H, Czernichow S, Uddén
Hemmingsson J, Hjelmesæth J, Hoffmann Morville T, Koroleva A, Skov
Neergaard J, Vélez Sánchez P, Wharton S, et al: Once-weekly
semaglutide in persons with obesity and knee osteoarthritis. N Engl
J Med. 391:1573–1583. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Zhu H, Zhou L, Wang Q, Cai Q, Yang F, Jin
H, Chen Y, Song Y and Zhang C: Glucagon-like peptide-1 receptor
agonists as a disease-modifying therapy for knee osteoarthritis
mediated by weight loss: Findings from the Shanghai Osteoarthritis
Cohort. Ann Rheum Dis. 82:1218–1226. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Li J, Zhang B, Liu WX, Lu K, Pan H, Wang
T, Oh CD, Yi D, Huang J, Zhao L, et al: Metformin limits
osteoarthritis development and progression through activation of
AMPK signalling. Ann Rheum Dis. 79:635–645. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Hou J, Lin Y, Zhu C, Chen Y, Lin R, Lin H,
Liu D, Guan D, Yu B, Wang J, et al: Zwitterion-lubricated hydrogel
microspheres encapsulated with metformin ameliorate age-associated
osteoarthritis. Adv Sci (Weinh). 11:e24024772024. View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Yan S, Dong W, Li Z, Wei J, Han T, Wang J
and Lin F: Metformin regulates chondrocyte senescence and
proliferation through microRNA-34a/SIRT1 pathway in osteoarthritis.
J Orthop Surg Res. 18:1982023. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Wang C, Yang Y, Zhang Y, Liu J, Yao Z and
Zhang C: Protective effects of metformin against osteoarthritis
through upregulation of SIRT3-mediated PINK1/Parkin-dependent
mitophagy in primary chondrocytes. Biosci Trends. 12:605–612. 2019.
View Article : Google Scholar
|
|
219
|
Li D, Ruan G, Zhang Y, Zhao Y, Zhu Z, Ou
Q, Huang H, Chen J, Han W, Tang S, et al: Metformin attenuates
osteoarthritis by targeting chondrocytes, synovial macrophages and
adipocytes. Rheumatology (Oxford). 62:1652–1661. 2023. View Article : Google Scholar
|
|
220
|
Lambova SN: Pleiotropic effects of
metformin in osteoarthritis. Life (Basel). 13:4372023.PubMed/NCBI
|
|
221
|
Li BZ, Wei HX, Li SZ, Yang YZ, Zhang AR
and Guo HZ: Update on metformin for osteoarthritis treatment.
Inflammopharmacology. 33:5963–5975. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Liu Z, Huang J, Wang X, Deng S, Zhou J,
Gong Z, Li X, Wang Y, Yang J and Hu Y: Dapagliflozin suppress
endoplasmic reticulum stress mediated apoptosis of chondrocytes by
activating Sirt1. Chem Biol Interact. 384:1107242023. View Article : Google Scholar : PubMed/NCBI
|
|
223
|
El-Demerdash AA, Darwish SF, El-Derany MO
and El-Demerdash E: Dapagliflozin targets the crosstalk between
apoptosis, autophagy, and Hedgehog signaling pathways through AMPK
activation in the adjuvant-induced arthritic rat model.
Inflammopharmacology. 33:3157–3176. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Zhao M, Song X, Chen H, Ma T, Tang J, Wang
X, Yu Y, Lv L, Jia L and Gao L: Melatonin prevents chondrocyte
matrix degradation in rats with experimentally induced
osteoarthritis by inhibiting nuclear factor-κB via SIRT1.
Nutrients. 14:39662022. View Article : Google Scholar
|
|
225
|
Park S and Shin BK: Intermittent fasting
with a high-protein diet mitigated osteoarthritis symptoms by
increasing lean body mass and reducing inflammation in
osteoarthritic rats with Alzheimer's disease-like dementia. Br J
Nutr. 127:55–67. 2022. View Article : Google Scholar
|
|
226
|
Qian YX, Rao SS, Tan YJ, Wang Z, Yin H,
Wan TF, He ZH, Wang X, Hong CG, Zeng HJ, et al: Intermittent
fasting targets osteocyte neuropeptide Y to relieve osteoarthritis.
Adv Sci (Weinh). 11:e24001962024. View Article : Google Scholar : PubMed/NCBI
|
|
227
|
Sun N, Zhao Y, Wang J, Zhang A and He Y:
Intermittent fasting in osteoarthritis: From mechanistic insights
to therapeutic potential. Front Nutr. 12:16048722025. View Article : Google Scholar : PubMed/NCBI
|
|
228
|
Sharma L: Osteoarthritis of the knee. N
Engl J Med. 384:51–59. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
229
|
Conaghan PG, Cook AD, Hamilton JA and Tak
PP: Therapeutic options for targeting inflammatory osteoarthritis
pain. Nat Rev Rheumatol. 15:355–363. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Lu Y, Yin Y, Kats ER, Sun J, Liu S and Lin
H: Estrogen receptor-α loss accelerates cartilage degradation
through CLEC3B-mediated chondrocyte hypertrophy and inflammation.
Osteoarthritis Cartilage. 33:1443–1453. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Jin WJ, Jiang SD, Jiang LS and Dai LY:
Differential responsiveness to 17β-estradiol of mesenchymal stem
cells from postmenopausal women between osteoporosis and
osteoarthritis. Osteoporos Int. 23:2469–2478. 2012. View Article : Google Scholar
|
|
232
|
Montemor CN, Fernandes MTP, Marquez AS,
Bignardi PR, Poli RC, Gâmbaro GA, da Silva RA, Ngomo S and
Fernandes KBP: Impact of reduced vitamin D levels on pain,
function, and severity in knee or hip osteoarthritis. Nutrients.
17:4472025. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Batushansky A, Zhu S, Komaravolu RK, South
S, Mehta-D'souza P and Griffin TM: Fundamentals of OA. An
initiative of osteoarthritis and cartilage. Obesity and metabolic
factors in OA. Osteoarthritis Cartilage. 30:501–515. 2022.
View Article : Google Scholar
|
|
234
|
Rogers-Soeder TS, Lane NE, Walimbe M,
Schwartz AV, Tolstykh I, Felson DT, Lewis CE, Segal NA and Nevitt
MC; Multicenter Osteoarthritis (MOST) Study Group: Association of
diabetes mellitus and biomarkers of abnormal glucose metabolism
with incident radiographic knee osteoarthritis. Arthritis Care Res
(Hoboken). 72:98–106. 2020. View Article : Google Scholar
|
|
235
|
Man TM, Ma Y, Zhao YG, He QS, Li GS and Wu
XF: Machine learning-driven insights into lipid metabolism and
inflammatory pathways in knee osteoarthritis. Front Nutr.
12:15520472025. View Article : Google Scholar : PubMed/NCBI
|
|
236
|
Awan UN, Waraich RS, Nangrejo R, Noor SS,
Siddiqui IA and Ikram K: RAGE signalling contributes to oxidative
stress and inflammation in knee osteoarthritis patients with
metabolic syndrome. Clin Exp Rheumatol. 42:2258–2264.
2024.PubMed/NCBI
|
|
237
|
Xiang W, Zhang T, Li B, Li S, Zhang B,
Fang S, Chen L, Gong Y, Huang B, Feng D, et al: Senescent
macrophages induce ferroptosis in skeletal muscle and accelerate
osteoarthritis-related muscle atrophy. Nat Aging. 5:1295–1316.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Gao Q, Yao D, Yin Z, Yu G, Shi B and Wang
J: Comprehensive multi-omics approach reveals potential therapeutic
targets and agents for osteoarthritis. Postgrad Med J. 101:464–474.
2025. View Article : Google Scholar
|
|
239
|
Cai Y, Yu D, Meng J, Qiu Y, Liu J and Yao
J: Multi-omics analysis and validation of autophagy-related
diagnostic biomarker in osteoarthritis. Ann Med. 57:25480452025.
View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Jayakumar P, Moore MG, Furlough KA, Uhler
LM, Andrawis JP, Koenig KM, Aksan N, Rathouz PJ and Bozic KJ:
Comparison of an artificial intelligence-enabled patient decision
aid vs educational material on decision quality, shared
decision-making, patient experience, and functional outcomes in
adults with knee osteoarthritis: A randomized clinical trial. JAMA
Netw Open. 4:e20371072021. View Article : Google Scholar : PubMed/NCBI
|
|
241
|
Saxer F, Jansen G, Bierma-Zeinstra SMA,
Holzhauer B, Demanse D, Melnick J, Vukadinovic Greetham D, Rall T,
Mesenbrink P and Schieker M: Why is there no treatment for
osteoarthritis-opportunity for AI based big data analytics to
advance the field. Osteoarthritis Cartilage. 34:657–666. 2026.
View Article : Google Scholar
|
|
242
|
Collins KH, Lenz KL, Welhaven HD, Ely E,
Springer LE, Paradi S, Tang R, Braxton L, Akk A, Yan H, et al:
Adipose-derived leptin and complement factor D mediate
osteoarthritis severity and pain. Sci Adv. 11:eadt59152025.
View Article : Google Scholar : PubMed/NCBI
|
|
243
|
Vincent TL: OA synovial fluid: Biological
insights into a whole-joint disease. Osteoarthritis Cartilage.
30:765–766. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
244
|
Tomura T, Ishii T, Kasahara N and Nishii
Y: Dihydrotestosterone and 17β-estradiol modulate TMJ
osteoarthritis development and reveal sex-specific differences in
pathogenesis. Sci Rep. 15:187402025. View Article : Google Scholar
|
|
245
|
Zhang S, Wang D, Zhao J, Zhao H, Xie P,
Zheng L, Sheng P, Yuan J, Xia B, Wei F and Zhang Z: Metabolic
syndrome increases osteoarthritis risk: Findings from the UK
Biobank prospective cohort study. BMC Public Health. 24:2332024.
View Article : Google Scholar : PubMed/NCBI
|
|
246
|
Walrabenstein W, Wagenaar CA, van de Put
M, van der Leeden M, Gerritsen M, Twisk JWR, van der Esch M, van
Middendorp H, Weijs PJM, Roorda LD and van Schaardenburg D: A
multidisciplinary lifestyle program for metabolic
syndrome-associated osteoarthritis: the 'Plants for Joints'
randomized controlled trial. Osteoarthritis Cartilage.
31:1491–1500. 2025. View Article : Google Scholar
|
|
247
|
Pragasam SSJ and Venkatesan V: Metabolic
syndrome predisposes to osteoarthritis: Lessons from model system.
Cartilage. 13(1 Suppl): 1598S–1609S. 2021. View Article : Google Scholar
|
|
248
|
Hernandez PA, Bradford JC, Brahmachary P,
Ulman S, Robinson JL, June RK and Cucchiarini M: Unraveling
sex-specific risks of knee osteoarthritis before menopause: Do sex
differences start early in life? Osteoarthritis Cartilage.
32:1032–1044. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
249
|
Fan Y, Bian X, Meng X, Li L, Fu L, Zhang
Y, Wang L, Zhang Y, Gao D, Guo X, et al: Unveiling inflammatory and
prehypertrophic cell populations as key contributors to knee
cartilage degeneration in osteoarthritis using multi-omics data
integration. Ann Rheum Dis. 83:926–944. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
250
|
Wu Y, Liu J, Yu W, Wang X, Li J and Zeng
W: Single-cell transcriptome and multi-omics integration reveal
ferroptosis-driven immune microenvironment remodeling in knee
osteoarthritis. Front Immunol. 16:16083782025. View Article : Google Scholar : PubMed/NCBI
|
|
251
|
Castagno S, Birch M, van der Schaar M and
McCaskie A: Predicting rapid progression in knee osteoarthritis: A
novel and interpretable automated machine learning approach, with
specific focus on young patients and early disease. Ann Rheum Dis.
84:124–135. 2025. View Article : Google Scholar : PubMed/NCBI
|
